Literature DB >> 7946448

Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects.

I Lax1, H Blomgren, I Näslund, R Svanström.   

Abstract

A method for stereotactic high-dose radiotherapy of malignancies in the abdomen has been developed. A stereotactic frame for the body has been developed and a method for fixation of the patient in the frame is described. The reproducibility in the stereotactic system of tumours in the liver and the lung was found to be within 5-8 mm for 90% of the patient set-ups. The diaphragmatic movements were reduced to 5-10 mm, by applying a pressure on the abdomen. An analytical method is used to calculate dose distributions for a continuum of beams in an isocentric treatment technique. The advantage of a heterogeneous target dose is demonstrated and proposed for the present application. A non-coplanar treatment technique, using eight individually shaped beams is proposed and has been used for patient treatments. The dose distribution for a patient with a metastasis in the liver is shown as well as dose volume histograms for the target and the liver.

Entities:  

Mesh:

Year:  1994        PMID: 7946448     DOI: 10.3109/02841869409121782

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  91 in total

1.  Stereotactic conformal radiotherapy of hepatic metastases:clinical analysis of 8 cases.

Authors:  Wei-Sheng Zhao; Da-Shi Zhi; Bo-Ping Liu; Wei Jiang; Zheng Cong; Cheng Dong
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

2.  A prospective study of quality of life including fatigue and pulmonary function after stereotactic body radiotherapy for medically inoperable early-stage lung cancer.

Authors:  Gregory M M Videtic; Chandana A Reddy; Lisa Sorenson
Journal:  Support Care Cancer       Date:  2012-06-02       Impact factor: 3.603

3.  Preliminary study of stereotactic radiotherapy for lung cancer.

Authors:  G Hu; S Yu; Y Chen; H Huang; C Hu
Journal:  J Tongji Med Univ       Date:  2000

Review 4.  The evolving role of stereotactic radiosurgery and stereotactic radiation therapy for patients with spine tumors.

Authors:  Jack P Rock; Samuel Ryu; Fang-Fang Yin; Faye Schreiber; Muwaffak Abdulhak
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

5.  [Stereotactic radiation therapy for liver metastases].

Authors:  K K Herfarth; J Debus
Journal:  Chirurg       Date:  2005-06       Impact factor: 0.955

Review 6.  Establishing the Impact of Vascular Damage on Tumor Response to High-Dose Radiation Therapy.

Authors:  Katherine D Castle; David G Kirsch
Journal:  Cancer Res       Date:  2019-08-19       Impact factor: 12.701

Review 7.  Alternatives to surgery in early stage disease-stereotactic body radiotherapy.

Authors:  Meredith Elana Giuliani; Andrea Bezjak
Journal:  Transl Lung Cancer Res       Date:  2013-10

8.  Management of three-dimensional intrafraction motion through real-time DMLC tracking.

Authors:  Amit Sawant; Raghu Venkat; Vikram Srivastava; David Carlson; Sergey Povzner; Herb Cattell; Paul Keall
Journal:  Med Phys       Date:  2008-05       Impact factor: 4.071

Review 9.  [Stereotactic irradiation of lung tumors].

Authors:  H Hof; K Herfarth; J Debus
Journal:  Radiologe       Date:  2004-05       Impact factor: 0.635

10.  Cardiac embolization of an implanted fiducial marker for hepatic stereotactic body radiotherapy: a case report.

Authors:  Hooman Hennessey; David Valenti; Tatiana Cabrera; Valerie Panet-Raymond; David Roberge
Journal:  J Med Case Rep       Date:  2009-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.